Jci_page_head_homepage_01 Jci_page_head_homepage_02
Cecile M. Fremond, Vladimir Yeremeev, Delphine M. Nicolle, Muazzam Jacobs, Valerie F. Quesniaux, Bernhard Ryffel
Published in Volume 114, Issue 12
J Clin Invest. 2004; 114(12):1790–1799 doi:10.1172/JCI21027
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

MyD88–/– mice are unable to control an MTB infection. MyD88–/– (open circles), TNF–/– (open squares), and wild-type (filled squares) mice were exposed to a low aerogenic dose of MTB H37Rv (200 CFU per mouse i.n.) and monitored for body weight (A; mean values of n = 6–8 mice per group from 1 representative experiment out of 7 independent experiments) and survival (B; n = 13–24 mice pooled from several experiments; P – 0.01 between MyD88–/– or TNF–/– mice and wild-type controls, and between TNF- and MyD88-deficient mice). (C) Lung wet weight of TNF–/– mice (gray bars), MyD88–/– mice (white bars), and wild-type controls (black bars) were measured 17 and 27 days after infection. The numbers of viable bacteria present in the lungs (D) and spleen (E) of MyD88–/– (white bars) and wild-type (black bars) mice were determined after 27 days of infection (mean ± SD of n = 3–4 lung or n = 5–7 spleen samples from 1 representative experiment out of 2 or 3 independent experiments, respectively; **P – 0.01).